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Abstract
The actions of luteinizing hormone (LH) mediated through its receptor (LHR) are critical for
testicular steroidogenesis and Leydig cell differentiation. We have previously characterized
transgenic mice expressing a genetically engineered, constitutively active yoked hormone-receptor
complex (YHR), in which a fusion protein of human chorionic gonadotropin (hCG) was covalently
linked to LHR. Elevated testosterone levels were detected in male mice expressing YHR (YHR+) at
3 and 5 weeks of age, accompanied by decreases in testicular weight and serum levels of LH and
FSH. Here we report a temporal study to identify testicular genes whose expression is altered in
YHR+ mice during postnatal development. The mRNA expression levels for the steroidogenic
enzymes, P450 17α-hydroxylase, 17β-hyroxysteroid dehydrogenase3 and 5α-reductase1 were down-
regulated in 3 and 5 week old YHR+ testis. This result coupled with an immunohistochemical analysis
of Leydig cell specific proteins and quantification of Leydig cell numbers identified a decrease in
adult Leydig cells in YHR+ mice. Surprisingly, no change was detected for cytochrome P450 side-
chain cleavage or steroidogenic acute regulatory protein RNA levels between WT and YHR+ mice.
In contrast, mRNA levels for insulin-like growth factor binding protein 3 were up-regulated in 3 and
5 week old YHR+ mice. The mRNA levels for several germ cell-specific proteins were up-regulated
at 5 weeks of age in both WT and YHR+ mice. We conclude that premature high levels of testosterone
alter the expression of a select number of testicular genes and impair the differentiation of adult
Leydig cells in mice.
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1. Introduction
The gonadotropins, LH, human chorionic gonadotropin (hCG) and follicle stimulating
hormone (FSH) and their respective seven transmembrane G protein-coupled receptors, LHR
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(which binds both LH and hCG) and FSHR, are critical for reproductive function. LH, hCG
and FSH are heterodimeric hormones consisting of a common α-subunit and a β-subunit that
is hormone specific (Hearn and Gomme, 2000). In males, LHR is expressed in the Leydig cells
of the testis where its primary function is the stimulation of steroidogenesis. Activation of
FSHR in Sertoli cells is important in testicular development and spermatogenesis (Themmen
and Huhtaniemi, 2000). Both receptors signal primarily through the Gαs mediated cAMP
pathway. Additionally, LHR activates the phospholipase C/inositol phosphate pathway
(Fanelli et al., 2001; Ascoli et al., 2002) as well as the mitogenic ERK1/2 cascade in MA-10
Leydig cells and in primary cultures of rat Leydig cells (Hirakawa et al., 2002; Shiraishi and
Ascoli, 2007). Several activating or gain-of-function germ-line mutations in human LHR have
been identified in males with gonadotropin-independent precocious puberty, characterized by
prepubertal increases in testosterone and Leydig cell hyperplasia (Themmen and Huhtaniemi,
2000; Themmen, 2005). In contrast, inactivating mutations in LHR result in male
pseudohermaphroditism and Leydig cell hypoplasia (Themmen and Huhtaniemi, 2000;
Themmen, 2005).
Previous studies with LHR knock-out mice have demonstrated that, unlike the situation in
humans, sexual development in mice is normal until birth (Lei et al., 2001; Zhang et al.,
2001). However, postnatal Leydig cell development, steroidogenesis and spermatogenesis are
blocked (Lei et al., 2004; Zhang et al., 2004). Similar results are obtained with the LHβ knock-
out mice (Ma et al., 2004), illustrating the important role of LH in Leydig cell development
and steroidogenesis.
We have previously reported the phenotypic characterization of a transgenic mouse model
expressing a genetically engineered, constitutively active hCG-LHR complex (YHR+)
(Meehan et al., 2005). In this construct (YHR), a fusion protein containing the β and α-subunits
of hCG was covalently linked to LHR in a single polypeptide chain (Wu et al., 1996). In cell
culture, YHR exhibited constitutive activity increasing the basal levels of both cAMP and IP3
(Meehan and Narayan, 2007). In male YHR+ mice, testosterone levels and seminal vesicle
weights were elevated at the ages of 3 and 5 weeks in comparison to wild type (WT) mice
(Meehan et al., 2005) while the serum levels of LH, FSH and testicular weights were decreased
at these ages. However, testosterone and LH levels were not different in adult WT and
YHR+ mice (8 and 12 weeks of age). In contrast, serum FSH levels and testes weights remained
decreased in adult animals. The smaller testes size in the YHR+ mice was attributed to a
significant reduction in tubule size. In contrast to the precocious puberty observed in humans
harboring a constitutively active mutant LHR, YHR+ mice do not show any signs of advanced
puberty and there was no evidence that spermatogenesis was accelerated in these mice (Meehan
et al., 2005).
To study the molecular basis for the histological and endocrine changes observed as a result
of constitutive LHR signaling, we have examined the expression of proteins that are important
in testicular endocrine function and growth and differentiation during prepubertal and adult
stages of development in WT and YHR+ mice. Our results show that there are alterations in
the expression of several testicular genes and impairment in postnatal Leydig cell development.
2. Materials and Methods
2.1. Animal husbandry
We have previously described the generation and phenotypic characterization of transgenic
mice expressing a yoked hormone receptor complex (YHR) (Meehan et al., 2005). Briefly,
transgenic mice expressing YHR (YHR+) under the control of the inhibin α-subunit promoter
were bred with C57BL/6J mice. The mice were genotyped by PCR of tail DNA as described
previously (Meehan et al., 2005). The mice were maintained in a conventional colony with a
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12h light, 12h dark cycle and fed a standard laboratory chow (Purina Labdiet 5008). All animal
studies were approved by the Institutional Animal Care and Use Committee at Southern Illinois
University and the University of Georgia.
2.2. RNA isolation, cDNA synthesis and real-time RT-PCR
Testes were dissected from WT and YHR+ mice at 3, 5 and 8 weeks of age and flash frozen
in liquid nitrogen. Total RNA was extracted from testis after homogenization in RNA Stat-60
(Tel-test Inc., Friendswood, TX) following the manufacturer’s directions, and RNA
concentrations were determined by spectrophotometry. RNA was treated with DNase I (DNA-
free kit, Ambion, Austin, TX) for 30 min at 37 °C to remove potential contaminating DNA
followed by treatment with inactivating reagent to remove the DNase. cDNA was synthesized
using the Retroscript Kit (Ambion, Austin, TX). Briefly, 1 μg of DNase treated RNA was
incubated for 1 h at 44 °C with 10 μM random decamers, 1 μM deoxy-NTP mixture, 10 U
RNase inhibitor and 100 U Moloney murine leukemia virus reverse transcriptase in a final
volume of 20 μl of 1x reverse transcriptase buffer. The reaction was terminated by heating at
94 °C for 10 min.
Real-time RT-PCR analysis for LHR (Lhcgr) was performed on a MyIQ real time PCR
detection system (Bio-Rad Laboratories, Hercules, CA) using Sybr green PCR master mix
(Bio-Rad Laboratories, Hercules, CA). The forward primer was designed to anneal to the signal
sequence of mLHR (5′ GGTGCTGGCAATGCTGGTG 3′) and the reverse primer within the
sequence of the mature protein (5′ CGCACTCGCAGGGCTCAG 3′). 10 ng of cDNA was used
in a 25 μl reaction volume and samples and controls were run in duplicate. A template negative
control and a calibrator sample, prepared by mixing equal amounts of RNA from all the
samples, were also analyzed. In addition, a control without reverse transcriptase was included
to ensure the effectiveness of the DNase treatment. Ribosomal protein S2 (Rps 2) was used as
the endogenous control because its levels did not change significantly in the testis at the
different ages. Four independent samples of each genotype were analyzed. The amplification
protocol consisted of an initial denaturation at 95 °C for 3 min followed by 35 cycles for 15
sec at 95 °C and 57 °C annealing for 1 min. Amplification was followed by melt curve analysis
to ensure that no primer-dimer amplification occurred. For each primer, a standard curve was
made by a dilution series of a reference testis RNA sample to ensure that amplification
efficiencies were not significantly different. The data were analyzed by the ΔΔCT method
(Livak and Schmittgen, 2001). The difference in the CT value between Lhcgr and Rps 2 was
defined at ΔCT. The difference in ΔCT between the gene of interest and calibrator was defined
as ΔΔCT. The fold-change in Lhcgr normalized to Rps 2 and relative to calibrator was defined
by 2−ΔΔCT.
2.3. Real time RT-PCR with gene expression cards
7900HT microfluidic cards (configuration 8) were designed and purchased from Applied
Biosystems (Foster City, CA). Each of these 384 well Low Density Array cards contained 95
gene targets and one 18s rRNA internal control. The list of genes is provided in Supplementary
Table 1. Total RNA was prepared as described above and submitted to the Functional Genomics
Resource Facility at the University of Georgia. The integrity of the RNA was verified and
quantified using a RNA 6000 Series II Nano Assay (Agilent Technologies) and the Agilent
2100 Bioanalyzer. cDNA was synthesized from 500 ng of total RNA in a 20 μl reaction using
the cDNA archive kit (Applied Biosystems, Foster City, CA) according to the manufacturer’s
protocols. Quantitative PCR (TaqMan) assays were performed using the TaqMan universal
PCR master mix on the ABI PRISM Sequence Detection System. 100 ng of cDNA was injected
into each port and the cycle conditions were 94.5 °C for 15 min followed by 40 cycles of 97 °
C for 30 s and 59.7 °C for 1 min. Three independent samples of each genotype (WT and
YHR+) were evaluated in duplicate at 3, 5 and 8 weeks of age. In addition, a calibrator sample
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was prepared by mixing equal amounts of RNA from all the samples. The data were analyzed
with the ABI Prism SDS 2.2 software (Applied Biosystems, Foster City, CA) using the
automatic threshold cycle (CT) setting and relative quantitation (2−ΔΔCT) method (Livak and
Schmittgen, 2001). The CT value of the internal control (18S rRNA) was subtracted from the
gene of interest to obtain the ΔCT value for each gene. The difference in ΔCT between the gene
of interest and calibrator was defined as ΔΔCT and the relative quantity by 2−ΔΔCT. The fold-
changes in YHR+ expression relative to WT at each age (Fig. 1) were determined by the
ΔΔCT values obtained by subtracting the ΔCT value for WT from that for YHR+. The data
were visualized using Java TreeView (Saldanha, 2004).
2.4. Western blot analysis
Testes were dissected and flash frozen in liquid nitrogen. Total protein lysates from testis of
three independent WT and YHR+ mice at each age were prepared by homogenization in lysis
buffer consisting of 50 mM Tris HCl, pH 7.8, 150 mM NaCl, 1% NP-40, 0.15% SDS, 1mM
DTT, 2 mM EDTA, 50% protease inhibitor cocktail (Sigma Chemicals, St. Louis, MO), 4 mM
sodium flouride, and 100 μM sodium vanadate followed by centrifugation at 13,000 × g for
30 min. The supernatant was collected and protein concentration determined by the Bradford
assay (Bio-Rad Laboratories, Hercules CA).
Total protein (50 μg) was resolved on 10% SDS/polyacrylamide gels under denaturing
conditions and transferred electrophoretically to Immobilon-P membrane (Millipore, Bedford,
MA). The membranes were blocked with LI-COR Odyssey blocking buffer (LI-COR
Biosciences, Lincoln, NE) diluted 1:1 with PBS for 1 h at room temperature followed by
incubation with primary antibodies overnight at 4 °C. All primary antibodies were diluted
1:2500 in 1:1 Odyssey blocking buffer/PBS. Primary antibodies used were goat anti-actin
(Santa Cruz Biotechnology, Santa Cruz, CA) as an internal control, along with one of the
following: rabbit anti-cytochrome P450 side chain cleavage (P450scc) (Millipore, Bedford,
MA) or rabbit anti-3β hydroxysteroid dehydrogenase 1 (3βHSD1) (provided by Dr. Anita
Payne, Stanford University, CA). The membrane was washed four times with PBS/0.1% Tween
20 and then incubated for 1 h with secondary antibody (donkey anti-goat IgG conjugated with
Alexa Fluor 680 (Invitrogen, Carlsbad, CA) and donkey anti-rabbit IgG conjugated with IRDye
800 (Rockland Immunochemicals, Gilbertsville, PA) diluted 1:10,000 in 1:1 Odyssey blocking
buffer/PBS. The membrane was washed three times in PBS/0.1% Tween with a final wash in
PBS. The membrane was scanned and the protein bands quantified with the Odyssey Infrared
Imaging System. The actin band is detected at 700 nM and the steroidogenic enzymes at 800
nM.
2.5. Immunohistochemistry
Testes from 3 WT and 3 YHR+ mice at 3, 5 and 8 weeks of age were fixed in Bouin’s solution
and embedded in paraffin. Serial sections (5 μm) of the testis were stained with hematoxylin
and eosin or were used to perform immunohistochemistry with a 1:400 dilution of P450scc,
1:800 dilution of 3βHSD1, 1:1000 dilution of cytochrome P450 17α-hydroxylase (P450c17)
(provided by Dr. Anita Payne, Stanford University, CA) and 1:75 dilution of 5α-reductase1
antibodies (provided by Dr. Bernard Robaire, McGill University, Canada). After incubation
for 1 h at room temperature, sections were incubated with biotinylated secondary antibody for
10 min followed by incubation with Vectastain Elite ABC reagent (Vector Labs, Burlingame,
CA). The antibody-antigen complexes were visualized with diaminobenzidine to produce
brown deposits and sections were counterstained with hematoxylin.
2.6. Leydig cell quantification
Leydig cell number was determined by an adaptation of the method described by Eacker et al.
(Eacker et al., 2008). Bouins fixed testes were cut in half and embedded in paraffin. 5μm serial
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sections were prepared and three nonadjacent sections that represented different regions of the
testis were stained with 3βHSD1 as described above to unambiguously identify the Leydig
cells. Five randomly chosen fields of defined area in each section were imaged using a 40 x
objective. All 3βHSD1 positive cells were counted and classified as either fetal (cells with
round nucleus present in distinct clusters), progenitor (spindle shaped) or adult (round) Leydig
cells. Five animals at each age and genotype were used for the analysis. Leydig cell density
was determined based on the number of cells in the defined area of the 5μm thick section. Total
number of Leydig cells per testis was determined by multiplying the cell density by testis
volume. Testis weight was used as an estimate of testis volume (mm3) because the density of
the testis is approximately 1mg/ml (Mori and Christensen, 1980).
2.7. Statistical Analysis
Real time RT-PCR and Western data were normalized by logarithmic transformation before
analysis. Data were analyzed by 2-way ANOVA and Bonferroni post-tests using the Prism
software program (GraphPad Software, Inc., San Diego, CA, USA). All data are expressed as
mean ± SEM.
3. Results
3.1. Developmental changes in gene expression in the postnatal testis of WT and YHR+ mice
In order to assess quantitative changes in the expression of a large number of genes during
post-natal development of WT and YHR+ mice, gene expression microfluidic cards containing
95 gene targets and one endogenous control were used. The cards were designed to enable
analysis of testis and ovary RNA. The genes included those for the steroidogenic enzymes,
gonadotropin and steroid hormone receptors, cell cycle dependent proteins, signaling
molecules, apoptotic genes and sperm specific proteins including those implicated in sperm
motility. A list of these genes with their gene symbols is presented in Supplementary Table 1.
We analyzed the data for genes that were differentially expressed in YHR+ testis relative to
WT testis and for genes whose expression was altered during postnatal development. We chose
to examine expression at 3, 5 and 8 weeks of age because our previous studies had shown that
the endocrine changes of increased testosterone and decreased LH and FSH occurred in
YHR+ mice at the ages of 3 and 5 weeks (Meehan et al., 2005). At 3 and 5 weeks of age,
testicular testosterone levels in YHR+ mice were 18 ± 2.9 and 69.9 ± 5.1ng/g testis compared
to 1.5 ± 0.4 and 4.8 ± 0.9 ng/g testis in WT mice, respectively (Meehan et al., 2005; Meehan
and Narayan, 2007). Genes whose expression was below the recommended lower limit (CT
value greater than 34) were removed from the analysis (8 genes). A dendrogram of the fold
change (positive or negative) in gene expression in YHR+ mice relative to WT mice at each
age is shown in Figure 1A. The majority of genes showed less than 2-fold change in expression
between WT and YHR+ mice at any age. Three genes, encoding steroidogenic enzymes
P450c17 (Cyp17a1), 17β hydroxysteroid dehydrogenase3 (Hsd17b3) and steroid 5α-
reductase1 (Srd5a1) (Fig. 1B), showed a statistically significant 2-fold or greater
downregulation in 3 and 5 week old mice, while the only gene that was up-regulated was the
insulin like growth factor binding protein 3 (Igfbp3).
The expression of a subset of genes was altered during postnatal development but unchanged
between WT and YHR+ mice. These were germ cell specific genes that were expressed at low
or undetectable levels at 3 weeks, significantly up-regulated in 5 week-old mice and remained
unchanged at 8 weeks (Fig. 2). The exception was lactate dehydrogenase3 (Ldh3), which is
also germ cell specific but was not significantly altered between 3 and 8 weeks of age.
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We further examined the developmental changes in the genes that were differentially expressed
in YHR+ mice compared to WT mice (Fig. 3). IGFBP3 expressed in Sertoli and Leydig cells
was significantly up-regulated at 3 and 5 weeks of age in YHR+ testis but not at 8 weeks of
age. Its RNA levels decreased during pubertal development with lowest levels seen in adult
mice of both genotypes. It was interesting that all the down-regulated genes were Leydig cell
specific. Expression levels of P450c17 RNA in YHR+ but not WT mice increase significantly
from 3 to 5 weeks of age. At 3 and 5 weeks of age, there is a significant reduction in P450c17
RNA levels compared to WT mice, but not in 8 week-old adult mice. Expression of 17β
hydroxysteroid dehydrogenase3 (17βHSD3), which catalyzes the last step in testosterone
biosynthesis (Fig. 1B), was significantly down-regulated in YHR+ mice compared to WT mice
at 3 and 5 weeks. This gene (Hsd17b3) is expressed only in adult Leydig cells (O’Shaughnessy
et al., 2002) and its expression is significantly up-regulated in 5 week-old WT mice consistent
with the timing of adult Leydig cell differentiation (Mendis-Handagma and Ariyaratne,
2001). However, 17βHSD3 RNA levels remain low in 5 week-old YHR+ mice and do not
increase until 8 weeks of age at which time their levels are still slightly lower than that seen in
WT mice. One possible explanation for the down-regulation of 17βHSD3 RNA levels is that
there is a decrease in the number of adult Leydig cells and a possible delay in their appearance
in YHR+ testis. In contrast to the expression pattern of 17βHSD3 RNA, the mRNA levels of
5α-reductase1 in WT mice are highest before puberty and decrease in the adult mouse. The
levels in YHR+ mice are significantly decreased at 3 and 5 weeks of age and do not vary during
development. Srd5a1 is expressed in high levels in immature adult Leydig cells (Mendis-
Handagma and Ariyaratne, 2001) again suggesting a decrease in the number of adult Leydig
cells in YHR+ mice at 3 and 5 weeks of age.
3.2. Alterations in Leydig cell number and differentiation in YHR+ mice
To further examine the prediction of decreased Leydig cell numbers in YHR+ mice, cell specific
expression of the Leydig cell specific proteins, P450scc, 3βHSD1, P450c17 and 5α-reductase1
were examined by immunohistochemistry of testicular sections (Fig. 4). Examination of
sections showed that the size of the Leydig cell clusters specifically stained with these
antibodies was smaller in YHR+ mice, particularly at 5 weeks of age. This difference persisted
at 8 weeks of age although it was less apparent. Specific 5α-reductase1 immunostaining of
Leydig cells was not detected in 8 week old WT and YHR+ testis consistent with a drop in
5α-reductase enzyme activity in adult Leydig cells (Benton et al., 1995;Ariyaratne et al.,
2000).
To validate this qualitative decrease observed in the Leydig cell population in YHR+ mice, we
performed a systematic histological analysis to estimate Leydig cell number as described in
Materials and Methods. Fetal Leydig cells (FLC) were only detected at 3 weeks of age. The
FLC density (cells/mm3) of WT mice was 3620 ± 259 compared to 7756 ± 2593 in YHR+
mice. Progenitor Leydig cell (PLC) density was not significantly different between WT and
YHR+ mice except at 8 weeks of age (Fig. 5A). However, there was a significant decrease in
PLC density in WT mice between 3 and 5 weeks of age and in YHR+ mice between 5 and 8
weeks of age. Adult Leydig cell (ALC) density on the other hand was significantly decreased
in YHR+ mice compared to WT mice at 3 and 5 weeks of age but not at 8 weeks of age (Fig.
5B) consistent with the relative changes in 17βHSD3 RNA levels seen previously (Fig. 3). The
testes of YHR+ mice are significantly smaller that WT mice at all ages (Fig. 5C) and these
testes weights were used to calculate the total number of Leydig cells in the WT and YHR+
testis. As shown in Fig. 5D, the total number of Leydig cells is significantly decreased in
YHR+ testis at all ages. Together, these data and the immunohistological data shown in Fig. 4
suggest that there is a delay in the differentiation of PLC to ALC and an overall decrease in
the number of Leydig cells in the YHR+ testis.
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3.3. Postnatal expression of Leydig cell specific genes
Since one of the major changes in YHR+ mice was an increase in testosterone levels at 3 and
5 weeks of age, we expected that the expression of steroidogenic enymes would be upregulated
in YHR+ mice. The enzymes/genes in the testosterone biosynthetic pathway and their relative
expression in YHR+ testis compared to WT are summarized in Fig. 1B. The first step in steroid
biosynthesis is the transport of cholesterol from the outer to inner mitochondrial membrane by
steroid acute regulatory protein (StAR). Although testicular expression of this gene (Star) was
up-regulated during postnatal development in both WT and YHR+ mice (data not shown), it
was unchanged between the genotypes (Fig. 1A and B). As Leydig cell numbers in YHR+ mice
are significantly less than in WT mice, we wanted to determine Star expression levels in WT
and YHR+ mice after correcting for Leydig cell number. The data shows that the StAR RNA
levels per cell were unchanged with age or genotype (Fig 6). The mRNA levels for P450scc
(Cyp11a1) and 3βHSD1 (Hsd3b1) also remain the same in WT and YHR+ mice after Leydig
cell number correction. Expression of these RNA transcripts per Leydig cell appears to decrease
with age although their expression levels before Leydig cell number correction remained
constant during pubertal development (data not shown). Since LHR activation in the Leydig
cells is the first step in the initiation of steroidogenesis, we examined its RNA expression during
development. Because the primer designed for the microfluidic cards would detect both LHR
and YHR, we performed a separate real time RT-PCR experiment for LHR (Lhcgr) wherein
one of the RT-PCR primers was designed to hybridize to the signal sequence of LHR and the
other in a sequence coding for the mature protein. This ensured that the primers would only
amplify LHR as YHR lacks the signal sequence. The data (Fig. 6) showed that LHR mRNA
levels, after correcting for Leydig cell numbers, are similar between WT and YHR+ mice.
Protein expression of two steroidogenic enzymes was examined by Western blot analysis.
Testis extracts prepared from 3, 5 and 8 week old mice and probed with antibody against
P450scc showed a specific band with an apparent molecular weight of 44 kDa (Fig. 7A).
Quantification of band intensity with β actin as loading control and corrected for Leydig cell
numbers, indicated that protein levels were similar in WT and YHR+ mice from 3 to 8 week
old WT testis. The levels of 3βHSD1 with an apparent molecular weight of 40 kDa were also
unchanged during development and between genotypes (Fig. 7B).
Discussion
In the present study, using a combination of gene expression and quantitative histological
analyses, we demonstrate that premature activation of LHR impairs the development of adult
Leydig cells in mice. The gene expression studies identified two patterns of changes (i) a subset
of genes that were up-regulated during postnatal development but unchanged with genotype
and (ii) genes whose levels were altered in YHR+ mice during development. Genes whose
expression was unchanged with genotype, but up-regulated from 3 to 5 weeks of age were
sperm specific genes expressed in meiotic spermatocytes, spermatids or during
spermiogenesis. The exception was Ldh3, which was already present at high levels in 3 week-
old mice. This is consistent with previous reports that demonstrated that Ldh3 expression is
detected in pachytene spematocytes as early as postnatal day 16 (Thomas et al., 1990). The
expression pattern of these genes is consistent with a spermatogenic wave of about 35 days in
mice and our previous observation that spermatogenesis is not initiated earlier in YHR+ mice
(Meehan et al., 2005).
Of those genes whose expression was altered in YHR+ mice, three genes encoding the
steroidogenic enzymes, P450c17, 5α-reductase1 and 17β-HSD3, were down-regulated in
YHR+ mice at 3 and 5 weeks of age, but not in adult mice, and the fourth gene encoding
IGFBP3, was up-regulated. Although the YHR+ mRNA levels are lower for P450c17 and 5α-
reductase1, the developmental profile of these genes is similar in WT and YHR+ mice. P450c17
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mRNA levels increase at 5 weeks preceding the pubertal rise in testosterone levels in WT mice.
In contrast, the mRNA levels for the testosterone metabolizing enzyme 5α-reductase1 are high
at 3 and 5 weeks and decline at 8 weeks as testosterone levels increase. The decrease in the
levels of P450c17 and 5α-reductase1 mRNA levels in YHR+ mice occurs at 3 and 5 weeks of
age when testosterone levels in these animals are elevated compared to WT mice (Meehan et
al., 2005). Previous studies have demonstrated that testosterone negatively regulates the mRNA
levels of P450c17 and 5α-reductase1 (Hales et al., 1987; Burgos-Trinidad et al., 1997; Pratis
et al., 2003). This difference is not seen at 8 weeks of age since testosterone levels are similar
in WT and YHR+ mice and any negative regulation would likely be the same in both genotypes.
In addition, the low levels of 5α-reductase1 in 3 and 5 week old YHR+ mice may be due to the
decreased levels of FSH measured in these mice (Meehan et al., 2005) and consistent with
previous studies that demonstrated that FSH positively regulates 5α-reductase1 mRNA (Pratis
et al., 2003). It is possible that the down-regulation of 5α-reductase1, which metabolizes
testosterone to 5α-dihydrotestosterone, may in turn contribute to the elevated testosterone
levels in YHR+ mice. The third down-regulated gene, Hsd17b3, encodes the enzyme required
for the last step in testosterone biosynthesis, the conversion of androstenedione to testosterone
(Fig. 1B). This gene is expressed predominantly in adult Leydig cells (O’Shaughnessy et al.,
2002), and its temporal expression in WT mice is consistent with the timing of adult Leydig
cell differentiation that has been previously reported (Mendis-Handagma and Ariyaratne,
2001; O’Shaughnessy et al., 2002). The temporal expression of Hsd17b3 in YHR+ mice
however is different and a significant increase in the mRNA levels does not occur till 8 weeks
of age suggesting a delay in adult Leydig cell development. However, the possibility that
testosterone also negatively regulates the expression of 17βHSD3 cannot be excluded.
It was surprising that the RNA levels of neither StAR nor P450scc, involved in the rate limiting
steps of testosterone biosynthesis, were up-regulated in YHR+ mice. The RNA and protein
levels for P450scc were maximal at 3 weeks suggesting that the enzyme and cholesterol levels
are sufficient to promote steroidogenesis in prepubertal YHR+ mice. The levels of 3βHSD1
mRNA and protein were unchanged between WT and YHR+ mice, in agreement with previous
studies indicating that expression of this gene is independent of LH (Baker et al., 2003; Zhang
et al., 2004).
During testicular development, there are two morphologically and functionally distinct
populations of Leydig cells (Habert et al., 2001). The first are the fetal Leydig cells (FLC) that
differentiate in fetal life, are present at birth and decline postnatally. The second are the adult
Leydig cells with steroidogenic potential that develop from mesenchymal precursor cells
through several steps of proliferation and differentiation (Mendis-Handagma and Ariyaratne,
2001; Ge et al., 2005; Ge and Hardy, 2007). In rodents, the spindle shaped PLC arise from the
differentiation of precursor cells at about 10–13 days. The PLCs are proliferative and express
the steroidogenic enzymes, P450scc, 3βHSD1 and P450c17 (Ariyaratne et al., 2000; Ge et al.,
2005). At around day 21, these cells begin differentiating into round immature Leydig cells
(ILC) and these are the predominant cell type between 28–56 days postnatally. ILCs express
high levels of 5α-reductase1 and the predominant steroid is 5α-reduced androgen. By postnatal
day 56, ILCs undergo a final transition to ALCs, express high levels of 17βHSD3, and
testosterone is the predominant androgen that is secreted by the testis. LH is critical for the
establishment of the adult Leydig cell population and androgens are required for the
differentiation of progenitor cells (Stocco et al., 1990; Murphy et al., 1994; Benton et al.,
1995).
Immunohistochemical analysis of testis sections with several Leydig cell specific steroidogenic
enzymes reveals that there is an apparent decrease in the number of immunopositive cells in
YHR+ mice. Quantitative analysis of PLCs and ALCs in WT and YHR+ testis showed a
significant difference in the ALC but not PLC density between genotypes at 3 and 5 weeks of
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age. Together, these studies indicate that differentiation of PLCs to ALCs is impaired in
YHR+ testis resulting in an overall decrease in the Leydig cell population YHR+ mice.
It is interesting that the only gene that was significantly up-regulated in our initial gene
expression screen was Igfbp3 that is produced by the prepubertal Sertoli cell (Smith et al.,
1992; Rappaport and Smith, 1995) as well as Leydig cells (Lin et al., 1993) and modulates the
biological activity of testicular insulin-like growth factor1 (IGF-1). Expression of IGFBP3
mRNA is negatively regulated by FSH (Smith et al., 1992; Rappaport and Smith, 1995).
Previous studies have shown that IGF-1 regulates the proliferation and differentiation of Leydig
cell precursors (Wang and Hardy, 2004). IGF-1 and LH act in concert to stimulate steroidogenic
enzyme gene expression (Wang et al., 2003), and IGFBP3 can neutralize the effects of IGF-1
on Leydig cell-induced steroidogenesis (Lin et al., 1993) and Leydig cell growth and
proliferation. Current evidence suggests that the role of FSH on Leydig cell development is
mediated through Sertoli cell secreted proteins. Two Sertoli cell factors, desert hedgehog and
platelet derived growth factor A have been implicated in Leydig cell development (Clark et
al., 2000; Gnessi et al., 2000). The decreased levels of FSH in YHR+ mice may, in addition to
increasing IGFBP3 mRNA levels, also affect expression of trophic factors required for Leydig
cell development.
Androgens produced by the FLCs in the neonatal testis may have an effect on adult Leydig
cell differentiation and both PLCs and ILCs have androgen receptors (Mendis-Handagma and
Ariyaratne, 2001). Studies suggest that androgens are stimulatory for some steps in Leydig cell
development and inhibitory to others. A previous report (Gaytan et al., 1994) suggested that
rats treated with hCG on days 2–4 showed an increase in the size and number of FLCs in 5 day
old rats but a long term decrease in the number of ALCs. On the other hand, administration of
hCG on days 20–22 showed similar short term and long term effects and resulted in an increase
in ALCs. FLCs express functional LHR and can respond to elevated LH or hCG with increased
testosterone and cell proliferation (Zhang et al., 1994; O’Shaughnessy et al., 1998). In
agreement with these observations, a recent study in hCG overexpressing transgenic mice
found that Leydig cell adenomas appeared only in the fetal population and not in the adult cells
(Ahtiainen et al., 2005). A similar situation may occur in YHR+ mice. The inhibin α-subunit
promoter that controls YHR expression, is active in FLCs (Majdic et al., 1997), and therefore,
it is likely that YHR is active in these cells. Our preliminary data suggests that testosterone
levels are elevated in 10 and 14 day-old mice (M. Coonce and P. Narayan, unpublished
observations). Whether these high levels of testosterone have a direct effect on the proliferation
of FLCs or differentiation of PLCs to ALCs in YHR+ mice remains to be determined.
In summary, we present evidence that elevated testosterone levels during early postnatal
development in the mouse impairs adult Leydig cell development and alters the expression of
some Leydig cell-specific genes required for steroidogenesis. We posit that testosterone exerts
its effects both directly on Leydig cells and indirectly by lowering the serum levels of LH and
FSH and altering the expression of factors regulated by these hormones and important for
Leydig cell maturation.
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Fig. 1A. Gene expression changes in YHR+ transgenic mice. The expression of 95 genes was
assayed by real-time RT-PCR using the ABI microfluidic cards. Data are expressed as fold
change in expression levels of each gene at 3, 5 and 8 weeks of age in YHR+ mice compared
to WT mice (n=3 for each age and genotype). Genes that showed a statistically significant
decrease in expression are indicated in red and increase in expression in blue. The full names
of the genes shown here with their GenBank accession numbers can be found in Supplementary
Table 1. B. Pathway of testosterone biosynthesis showing the Proteins/Genes required for each
step. Genes whose expression was down-regulated in 3 and 5 week old YHR+ mice compared
to WT mice (data from Figs. 1A and 3) are shown in bold.
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Expression of germ cell-specific genes. RNA levels and relative quantity were determined as
described for Figure 2. Data are expressed as mean of 3 animals per group. Catsper1, cation
channel of sperm 1; Fhl5, five and a half LIM domains 5; Gapds, glyceraldehydes-3-phosphate
dehydrogenase, spermatogenic; Ldh3, lactate dehydrogenase 3, sperm specific; Pgk2,
phosphoglycerate kinase 2; Prm1, 2, protamine 1 and 2; Sacy, soluble adenylyl cyclase; Tnp1,
2, transition protein 1 and 2. Significant differences (P<0.05) were observed between 3 and 5
weeks of age for all genes, except Ldh3, in WT and YHR+ mice.
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Expression of genes altered in YHR+ mice during postnatal development. Relative quantity
was determined by the ΔΔCT method and represents expression relative to a calibrator sample
prepared by mixing equal amounts RNA from all the samples. Data are expressed as mean ±
SEM of 3 animals for each group. The data were analyzed to (i) determine significant
differences between WT and YHR+ samples at each age and these are indicated by * (*, P <
0.05) and (ii) determine significant differences between ages within a genotype indicated by
the different letters above the bars (P < 0.05). Igfbp3, insulin like growth factor binding protein
3; Cyp17a1, cytochrome P450 17α-hydroxylase; Hsd17b3, 17β-hydroxysteroid
dehydrogenase 3; Srd5a1, steroid 5α-reductase 1.
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Immunohistochemical analysis of the steroidogenic enzymes in testis sections of WT and
YHR+ mice at 3, 5 and 8 weeks of age. Sections from 3 mice at each age and genotype were
analyzed. Representative photomicrographs show Leydig cell-specific staining, visualized by
the brown deposits, for all the enzymes. P450scc, cytochrome P450 side chain cleavage;
3βHSD1, 3β hydroxysteroid dehydrogenase 1; P450c17, cytochrome P450 17α-hydroxylase;
5α-R1, steroid 5α-reductase 1.
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Quantification of Leydig cell numbers. Cell density and total Leydig cell numbers were
determined as described in Materials and Methods. Data are expressed as mean ± SEM of 5
animals for each group. Significant differences between genotypes are indicated by * (*, P
<0.05; **, P< 0.01; ***, P < 0.001). Significant differences between ages within a genotype
are indicated by the different letters above the bars (P < 0.05). PLC, progenitor Leydig cell;
ALC, Adult Leydig cell; LC, Leydig cell.
Coonce et al. Page 18














Expression of genes required for Leydig cell steroidogenesis. Relative quantity was determined
by real-time RT-PCR with the mircrofluidic cards as in Fig. 3, except that the values were
normalized for Leydig cell numbers that had been determined for each age and genotype (Fig.
5). Expression of LHR was not determined with the microfluidic cards but with primers that
would distinguish the endogenous gene for LHR (Lhcgr) from YHR and Rps2 was used as the
internal control. Data are expressed as mean ± SEM of 3 animals for each group except for
Lhcgr which included 4 animals/group. Data were analyzed as described for Fig. 3. Significant
differences between ages within a genotype are indicated by the different letters (P < 0.05).
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Western Blot analysis of P450scc and 3βHSD1 in WT and YHR+ mice at different ages. Testis
extracts were resolved on a 10% SDS polyacrylamide gel, transferred to membrane and probed
with antibodies against P450scc, 3βHSD1 or β actin (loading control). Fluorescently labeled
secondary antibodies were utilized to detect proteins simultaneously. The blots were scanned
and the densities of the bands were quantified. The intensities of P450scc (A) and 3βHSD1
(B) bands relative to β actin and normalized for Leydig cell numbers are shown at each age.
A representative gel showing the bands for the protein of interest and βactin at the
corresponding ages and genotype is shown above the graph. The data are expressed as mean
± SEM of 3 animals per group.
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